Search results for "TC"

showing 10 items of 9993 documents

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a ra…

2009

Abstract Background This study assessed the activity of the mAb cetuximab in combination with cisplatin and 5-fluorouracil (5-FU) in advanced esophageal squamous cell carcinoma. Patients and methods For a maximum of six 29-day cycles, patients received cisplatin 100 mg/m2, day 1, plus 5-FU 1000 mg/m2, days 1–5 (CF), either alone or in combination with cetuximab (CET–CF; 400 mg/m2 initial dose followed by 250 mg/m2 weekly thereafter). The primary end point was tumor response. Tumor material was obtained for analysis of KRAS mutation status. Results Sixty-two eligible patients were included, 32 receiving CET–CF and 30 CF. Cetuximab did not exacerbate grade 3/4 toxicity, except for rash (6% ve…

AdultDiarrheaMalemedicine.medical_specialtyNeutropeniaTime FactorsEsophageal NeoplasmsCetuximabPhases of clinical researchKaplan-Meier EstimateAntibodies Monoclonal Humanizedmedicine.disease_causeGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalAgedCross-Over StudiesDose-Response Relationship DrugCetuximabbusiness.industryAntibodies MonoclonalNauseaHematologyMiddle AgedCombined Modality TherapySurvival AnalysisChemotherapy regimenSurgeryTreatment OutcomeOncologyEpidermoid carcinomaFluorouracilResponse Evaluation Criteria in Solid TumorsCarcinoma Squamous CellFemaleFluorouracilKRASCisplatinbusinessFollow-Up Studiesmedicine.drugAnnals of Oncology
researchProduct

Bowel Dilation Diagnosed Prenatally.

2017

AdultDiarrheamedicine.medical_specialtyCongenital chloride diarrheaColonMEDLINEPrenatal diagnosisGestational AgeConservative TreatmentUltrasonography Prenatal03 medical and health sciences0302 clinical medicinePregnancy030225 pediatricsPrenatal DiagnosismedicineHumansChloride-Bicarbonate AntiportersPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsCesarean SectionFollow up studiesInfant NewbornPregnancy OutcomeGestational ageGene Expression Regulation Developmentalmedicine.diseaseDilatationMagnetic Resonance ImagingSulfate TransportersPediatrics Perinatology and Child HealthFemaleUltrasonographybusinessBowel dilationMetabolism Inborn ErrorsFollow-Up StudiesThe Journal of pediatrics
researchProduct

Does Uterine Doppler Add Information to the Cerebroplacental Ratio for the Prediction of Adverse Perinatal Outcome at the End of Pregnancy?

2019

<b><i>Objective:</i></b> To evaluate whether the addition of the mean uterine arteries pulsatility index (mUtA PI) to the cerebroplacental ratio (CPR) improves its ability to predict adverse perinatal outcome (APO) at the end of pregnancy. <b><i>Methods:</i></b> This was a prospective study of 891 fetuses that underwent an ultrasound examination at 34–41 weeks. The CPR and the mUtA PI were converted into multiples of the median (MoM) and the estimated fetal weight (EFW) into centiles according to local references. APO was defined as a composite of abnormal cardiotocogram, intrapartum pH requiring cesarean section, 5′ Apgar score <7, n…

AdultEmbryologymedicine.medical_specialtyMultivariate analysisAdolescentUltrasonography Prenatal03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyInternal medicineMedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineProspective StudiesProspective cohort studyUnivariate analysisPregnancy030219 obstetrics & reproductive medicinebusiness.industryArea under the curveUnivariatePregnancy OutcomeObstetrics and GynecologyGeneral MedicineMiddle Agedmedicine.diseaseUterine ArteryROC CurvePediatrics Perinatology and Child HealthCardiologyApgar scoreFemaleAkaike information criterionbusinessFetal diagnosis and therapy
researchProduct

Quality of Life and Occupational Disability in Endocrine Orbitopathy

2009

SUMMARY Background: In endocrine orbitopathy (EO), disfiguring proptosis and diplopia impair patients' quality of life both at home and at work. Methods: From late 2006 to the beginning of 2008, 250 outpatients in an interdisciplinary thyroid and eye clinic filled out a questionnaire about their quality of life, occupational disability, and use of psychotherapy. 400 physicians who referred their EO patients to the clinic also participated in a survey on these issues. Results: 45% of the patients complained of restrictions in their daily activities, and 38% reported impaired selfperception. 36% were on sick leave because of EO. 28% were disabled, 5% had retired early, and 3% had lost their j…

AdultEmploymentMalemedicine.medical_specialtyActivities of daily livingAdolescentmedicine.medical_treatmentRisk AssessmentDisability EvaluationYoung AdultQuality of life (healthcare)Risk FactorsGermanySurveys and QuestionnairesmedicineHumansYoung adultAgedAged 80 and overDiplopiaRehabilitationbusiness.industryIncidenceIncidence (epidemiology)Endocrine orbitopathyGeneral MedicineMiddle AgedGraves OphthalmopathyPsychotherapyTreatment OutcomeSick leaveQuality of LifePhysical therapyOriginal ArticleFemalemedicine.symptombusinessDeutsches Ärzteblatt international
researchProduct

Burnout during a long-term rehabilitation: comparing low burnout, high burnout - benefited, and high burnout - not benefited trajectories.

2009

To focus rehabilitation activities among burnout clients more effectively, it is important to investigate who benefits from burnout interventions. This study (N=85) aimed at identifying burnout trajectories in terms of benefit, that is, subgroups of clients who share similar mean levels and changes in burnout during a one-year rehabilitation intervention (17 days in total) with a six-month follow-up. After identifying the burnout trajectories, the relations of the trajectories with factors describing the clients, antecedents, and consequences of burnout during the one-year intervention were examined. Three burnout trajectories were identified by growth mixture modeling: (a) low burnout (n=3…

AdultEmploymentTime Factorsmedicine.medical_treatmentEmotionsPsychological interventionBurnoutOccupational burnoutJob SatisfactionArts and Humanities (miscellaneous)Intervention (counseling)Surveys and QuestionnairesDevelopmental and Educational PsychologymedicineHumansBurnout ProfessionalInternal-External ControlLikelihood FunctionsRehabilitationDepressionRehabilitationFollow up studiesMiddle AgedPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMixture modelingPsychologyRehabilitation interventionsClinical psychologyAnxiety, stress, and coping
researchProduct

Once-daily tiotropium Respimat® 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma

2015

SummaryIntroductionOnce-daily tiotropium Respimat® 5 μg is an efficacious add-on therapy to inhaled corticosteroids (ICS) with or without long-acting β2-agonists in patients with symptomatic asthma. The objective of this study was to investigate whether the dosing regimen of tiotropium (once- versus twice-daily), delivered via the Respimat® SoftMist™ inhaler, affected 24-h bronchodilator efficacy and safety versus placebo Respimat® in patients with asthma who were symptomatic despite medium-dose ICS therapy.MethodsA randomised, double-blind, placebo-controlled, crossover study with 4-week treatment periods of tiotropium 5 μg (once-daily, evening) and 2.5 μg (twice-daily, morning and evening…

AdultEstoniaMalePulmonary and Respiratory MedicineVital capacityRespimatEveningAdolescentmedicine.drug_classPlaceboDouble-Blind MethodRisk FactorsAnticholinergic drugForced Expiratory VolumeGermanyBronchodilatorAdministration InhalationmedicineHumansDosingDosing regimenTiotropium BromideAgedCzech RepublicAsthmaLong-acting bronchodilatorCross-Over StudiesDose-Response Relationship Drugbusiness.industryTiotropiumInhalerMiddle Agedmedicine.diseaseLatviaAsthmaBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeBronchodilator efficacyAustriaAnesthesiaFemalebusinessRespiratory Medicine
researchProduct

An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: A meta-analysis

2017

The literature regarding exercise for people with established anxiety disorders is equivocal. To address this issue, we conducted a systematic review and meta-analysis investigating the benefits of exercise compared to usual treatment or control conditions in people with an anxiety and/or stress-related disorders. Major electronic databases were searched from inception until December/2015 and a random effect meta-analysis conducted. Altogether, six randomized control trials (RCTs) including 262 adults (exercise n=132, 34.74 [9.6] years; control n=130, 37.34 [10.0] years) were included. Exercise significantly decreased anxiety symptoms more than control conditions, with a moderate effect siz…

AdultExercise Physical activity Anxiety Stressmedicine.drug_classmedicine.medical_treatmentAnxietyAnxiolyticlaw.invention03 medical and health sciences0302 clinical medicineAnti-Anxiety AgentsRandomized controlled triallawmedicineAerobic exerciseHumans030212 general & internal medicineExerciseBiological PsychiatryRandomized Controlled Trials as TopicPanic disorderStress-related disordersmedicine.disease030227 psychiatryExercise TherapyCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomeAnti-Anxiety AgentsAnxietymedicine.symptomPsychologyStress PsychologicalClinical psychology
researchProduct

Efficacy of Focused Extracorporeal Shock Wave Therapy in Chronic Low Back Pain: A Prospective Randomized 3-Month Follow-Up Study.

2022

BACKGROUND Extracorporeal shock wave therapy (ESWT) is a modern physiotherapeutic method that is useful for treating musculoskeletal conditions. There are still limited data from well-designed studies evaluating the clinical efficiency of ESWT in low back pain (LBP). Therefore, this study aimed to assess the effectiveness of the focused ESWT (fESWT) in reducing pain and improving the functional status of patients with chronic LBP. MATERIAL AND METHODS The study involved 40 patients with L5-S1 discopathy with chronic LBP pain who were randomized into 2 groups: group A (n=20, mean age of 42.3±13.1 years) and group B (n=20, mean age of 45.4±14 years). Group A was an experimental group treated …

AdultExtracorporeal Shockwave TherapyLipopolysaccharidesGeneral MedicineMiddle Agedfunctional statusTreatment OutcomeRandomized controlled trialHumansProspective Studieschronic painLow Back PainPhysical Therapy ModalitiesFollow-Up StudiesMedical science monitor : international medical journal of experimental and clinical research
researchProduct

The Effectiveness Of Radial Extracorporeal Shock Wave Therapy In Patients With Chronic Low Back Pain: A Prospective, Randomized, Single-Blinded Pilot…

2019

Karolina Walewicz,1 Jakub Taradaj,2,3 Katarzyna Rajfur,1 Kuba Ptaszkowski,4 Michał Tomasz Kuszewski,2 Mirosław Sopel,5 Robert Dymarek5 1Faculty of Physiotherapy, Opole Medical School, Opole, Poland; 2Institute of Physiotherapy and Health Sciences, Academy of Physical Education, Katowice, Poland; 3College of Rehabilitation Sciences, University of Manitoba, Winnipeg, MB, Canada; 4Department of Physiotherapy, Wroclaw Medical University, Wroclaw, Poland; 5Department of Nervous System Diseases, Wroclaw Medical University, Wroclaw, PolandCorrespondence: Robert DymarekDepartment of Nervous System Diseases, Faculty of Health Sciences, Wroclaw Medical University, Bartla 5, Wroclaw 51-618, PolandTe…

AdultExtracorporeal Shockwave TherapyMaleExtracorporeal shock wave therapyVisual analogue scalePilot Projects03 medical and health sciences0302 clinical medicineHumansPain ManagementMedicinephysical therapySingle-Blind MethodIn patientProspective Studies030212 general & internal medicineOriginal ResearchPain Measurementfunctional statebusiness.industryESWTshock wavesGeneral MedicinePain scaleMiddle AgedLow back painChronic low back painOswestry Disability IndexTreatment OutcomeAnesthesiaClinical Interventions in AgingHomogeneous groupFemaleGeriatrics and Gerontologymedicine.symptombusinessLow Back Pain030217 neurology & neurosurgeryClinical Interventions in Aging
researchProduct

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures

2022

The maintenance of seizure control over time is a clinical priority in patients with epilepsy. The aim of this study was to assess the sustained seizure frequency reduction with adjunctive brivaracetam (BRV) in real-world practice. Patients with focal epilepsy prescribed add-on BRV were identified. Study outcomes included sustained seizure freedom and sustained seizure response, defined as a 100% and a ≥50% reduction in baseline seizure frequency that continued without interruption and without BRV withdrawal through the 12-month follow-up. Nine hundred ninety-four patients with a median age of 45 (interquartile range = 32-56) years were included. During the 1-year study period, sustained se…

AdultFreedomfocal seizuresEpilepsiesSettore MED/26Double-Blind MethodDrug Therapyantiseizure medication; brivaracetam; focal seizures; seizure freedom; sodium channel blockers; Adult; Double-Blind Method; Drug Therapy Combination; Freedom; Humans; Middle Aged; Pyrrolidinones; Seizures; Treatment Outcome; Anticonvulsants; Epilepsies PartialSeizuresseizure freedomHumansanti-seizure medication; focal seizures; epilepsyantiseizure medicationbrivaracetamanti-seizure medicationMiddle AgedPyrrolidinonesTreatment OutcomeNeurologysodium channel blockersCombinationepilepsyDrug Therapy CombinationAnticonvulsantsNeurology (clinical)Epilepsies PartialPartial
researchProduct